GLP-1 drugs: what Oregon Health Plan paid

Q: Does a paid prescription mean Oregon Health Plan covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Q: Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

Q: What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.

Oregon Health Plan shows a published payment figure for 6 of the 8 GLP-1 products this site tracks, in the latest federal quarter. This site has not yet read Oregon Health Plan's own coverage rule, so the figures below are a payment history and nothing here tells you what the program will decide next.

By the Covered Weight editorial team · Updated Aug 8, 2026. Research and sourcing by Evan Reid.

What Oregon Health Plan’s payment record shows

In 2026Q1, the product Oregon Health Plan paid for most often was Ozempic®, at 5,617 prescriptions¹⁹ of the 12,683 to 12,953^{1,7,13,19,25,43} across all 8 products, or 44 percent of the published count.

Oregon Health Plan itself reimbursed at least $10,763,348 for these products in the quarter, about $851 per prescription. Pharmacies were paid $11,244,106 in total, the difference being what other payers covered on the same claims. The costliest per prescription was Rybelsus®, at about $1,362.

Every dollar figure on this page is what pharmacies were paid, before rebates. Manufacturers pay Medicaid programs rebates on these products, the federal file states that its amounts are not reduced by them, and CMS publishes no rebate figure per drug. So what Oregon Health Plan finally kept is lower than what is shown here, by an amount this site cannot source.

Paid prescriptions per quarter, Oregon Health Plan. The line is what the federal file published and the axis starts at zero. The shaded band is what the file leaves possible above it: each withheld product code stands for between one and ten prescriptions, so a wide band means a heavily suppressed record rather than a busy one. A gap in the line is a quarter the file did not report, never a zero.

What Oregon Health Plan paid, product by product

For what each product is approved to treat, the split that decides most coverage questions, compare the products themselves.

Route, prescriptions, what Oregon Health Plan paid and what all payers paid, for each GLP-1 product, 2026Q1
Product	Paid through	Prescriptions	Shareof this program	Program paidbefore rebates	All payers	Program per Rx
tirzepatideZepbound®	Both	at least 2,058¹	16%	$2,130,765	$2,137,613	$1,035
tirzepatideMounjaro®	Both1,372 managed care, 226 direct	at least 1,598⁷	13%	$1,616,314	$1,801,339	$1,011
semaglutideWegovy®	Managed care	at least 465¹³	4%	$578,493	$594,481	$1,244
semaglutideOzempic®	Both5,270 managed care, 347 direct	5,617¹⁹	44%	$5,511,836	$5,772,948	$981
semaglutideRybelsus®	Both	at least 112²⁵	<1%	$152,493	$152,493	$1,362
liraglutideSaxenda®	Not published	Withheld	n/a	Not published	Not published	Not published
liraglutideVictoza®	Both	Withheld	n/a	Not published	Not published	Not published
liraglutideliraglutide (generic)	Both2,791 managed care, 12 direct	at least 2,803⁴³	22%	$773,447	$785,232	$276

Oregon Health Plan publishes claims on both routes: paid directly by the program, and paid through the managed-care plans it contracts with. The figures above combine the two, so which one your own card names decides who answers a question about your prescription.

Against enrollment, that is 11.4 to 11.7 prescriptions per thousand people enrolled in Oregon Health Plan, on an average of 1,111,552 enrollees across the quarter. A raw count compares programs by how many people they cover; this is the figure that compares them by what they paid for.

2026Q1 covers January through March 2026, and it is the newest quarter CMS has published; that file was released on July 10, 2026. Every count here is a prescription filled rather than a person: one patient on a monthly product contributes several in a quarter, so nothing on this page says how many people take these products.

The file withheld 25 of the 168 product-quarters it holds a row for here, which is 15 percent. Each withheld cell records prescriptions that were paid for and a count that is not disclosed, so any total on this page that includes one is a floor rather than a sum.

Ozempic® and Rybelsus® carry a published count in every one of the 21 quarters, which is the closest this record comes to showing a product paid for routinely.

21 quarters, 2021Q1 to 2026Q1

One quarter cannot tell you whether Oregon Health Plan pays for a product routinely or barely at all, and a single withheld cell reads as an absence when it is not.

Show what Oregon Health Plan paid for each product, quarter by quarter

Prescriptions Oregon Health Plan paid for, by product and quarter, 2021Q1 to 2026Q1
Product	2021Q1	2021Q2	2021Q3	2021Q4	2022Q1	2022Q2	2022Q3	2022Q4	2023Q1	2023Q2	2023Q3	2023Q4	2024Q1	2024Q2	2024Q3	2024Q4	2025Q1	2025Q2	2025Q3	2025Q4	2026Q1
tirzepatideZepbound®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁶No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁵No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable⁴Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable³Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable³Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q3)every reporting cell was withheld, so nothing is observable³Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q4)every reporting cell was withheld, so nothing is observable³Withheld2 of 2 product codes withheld	at least 29 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²At least$29,437 paid	at least 394 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²At least$400,543 paid	at least 917 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²At least$932,251 paid	at least 1,807 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²At least$1,859,611 paid	at least 2,058 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹At least$2,130,765 paid
tirzepatideMounjaro®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter¹²No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter¹¹No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter¹¹No row	withheld as a small cell paid prescriptions in the quarter (2022Q3)every reporting cell was withheld, so nothing is observable¹¹Withheld4 of 4 product codes withheld	at least 29 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld¹¹At least$27,654 paid	at least 89 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld¹⁰At least$91,072 paid	at least 203 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld¹⁰At least$197,162 paid	at least 277 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld¹⁰At least$266,801 paid	at least 403 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld¹⁰At least$392,985 paid	at least 412 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld⁹At least$415,517 paid	at least 558 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld⁹At least$560,015 paid	at least 608 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁹At least$599,886 paid	at least 773 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁹At least$759,122 paid	at least 1,028 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁸At least$990,777 paid	1,226 paid prescriptions in the quarter (2025Q2)⁸Count$1,191,516 paid	at least 1,508 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁸At least$1,485,355 paid	at least 1,662 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁸At least$1,616,705 paid	at least 1,598 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁷At least$1,616,314 paid
semaglutideWegovy®	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter¹⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter¹⁸No row	withheld as a small cell paid prescriptions in the quarter (2021Q3)every reporting cell was withheld, so nothing is observable¹⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable¹⁸Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q1)every reporting cell was withheld, so nothing is observable¹⁷Withheld1 of 1 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2022Q2)every reporting cell was withheld, so nothing is observable¹⁷Withheld3 of 3 product codes withheld	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter¹⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter¹⁷No row	withheld as a small cell paid prescriptions in the quarter (2023Q1)every reporting cell was withheld, so nothing is observable¹⁶Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable¹⁶Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q3)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2023Q4)every reporting cell was withheld, so nothing is observable¹⁶Withheld5 of 5 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2024Q1)every reporting cell was withheld, so nothing is observable¹⁵Withheld4 of 4 product codes withheld	at least 49 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld¹⁵At least$63,159 paid	at least 93 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld¹⁵At least$119,078 paid	at least 171 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld¹⁵At least$219,067 paid	at least 246 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld¹⁴At least$313,651 paid	at least 311 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld¹⁴At least$394,795 paid	at least 388 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld¹⁴At least$491,525 paid	at least 515 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld¹⁴At least$647,409 paid	at least 465 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld¹³At least$578,493 paid
semaglutideOzempic®range 3,967 to 7,023	at least 423 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld²⁴At least$361,741 paid	at least 456 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld²⁴At least$407,129 paid	at least 539 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld²⁴At least$476,149 paid	at least 827 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld²⁴At least$711,815 paid	at least 1,111 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²³At least$997,966 paid	at least 1,525 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²³At least$1,357,217 paid	at least 1,805 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²³At least$1,607,975 paid	at least 1,983 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²³At least$1,721,369 paid	at least 2,551 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²²At least$2,291,720 paid	at least 3,491 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²²At least$3,205,040 paid	at least 3,716 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²²At least$3,414,044 paid	3,967 paid prescriptions in the quarter (2023Q4)²²Count$3,685,646 paid	at least 4,972 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²¹At least$4,728,500 paid	6,470 paid prescriptions in the quarter (2024Q2)²¹Count$6,119,057 paid	7,023 paid prescriptions in the quarter (2024Q3)²¹Count$6,543,543 paid	at least 7,373 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²¹At least$6,839,235 paid	at least 7,515 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁰At least$7,113,638 paid	at least 7,312 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁰At least$6,885,419 paid	at least 6,854 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁰At least$6,531,763 paid	at least 6,604 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁰At least$6,339,821 paid	5,617 paid prescriptions in the quarter (2026Q1)¹⁹Count$5,511,836 paid
semaglutideRybelsus®	at least 40 paid prescriptions in the quarter (2021Q1)a floor, because some reporting cells were withheld³⁰At least$36,641 paid	at least 67 paid prescriptions in the quarter (2021Q2)a floor, because some reporting cells were withheld³⁰At least$69,308 paid	at least 75 paid prescriptions in the quarter (2021Q3)a floor, because some reporting cells were withheld³⁰At least$81,853 paid	at least 69 paid prescriptions in the quarter (2021Q4)a floor, because some reporting cells were withheld³⁰At least$71,430 paid	at least 87 paid prescriptions in the quarter (2022Q1)a floor, because some reporting cells were withheld²⁹At least$98,380 paid	at least 130 paid prescriptions in the quarter (2022Q2)a floor, because some reporting cells were withheld²⁹At least$148,449 paid	at least 132 paid prescriptions in the quarter (2022Q3)a floor, because some reporting cells were withheld²⁹At least$149,216 paid	at least 165 paid prescriptions in the quarter (2022Q4)a floor, because some reporting cells were withheld²⁹At least$184,016 paid	at least 202 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld²⁸At least$241,507 paid	at least 225 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld²⁸At least$260,535 paid	at least 251 paid prescriptions in the quarter (2023Q3)a floor, because some reporting cells were withheld²⁸At least$303,544 paid	at least 279 paid prescriptions in the quarter (2023Q4)a floor, because some reporting cells were withheld²⁸At least$338,980 paid	at least 258 paid prescriptions in the quarter (2024Q1)a floor, because some reporting cells were withheld²⁷At least$319,734 paid	at least 288 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld²⁷At least$347,570 paid	at least 268 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld²⁷At least$309,411 paid	at least 255 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld²⁷At least$298,937 paid	at least 246 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld²⁶At least$300,953 paid	at least 224 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld²⁶At least$265,424 paid	at least 185 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld²⁶At least$226,503 paid	at least 167 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld²⁶At least$208,204 paid	at least 112 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld²⁵At least$152,493 paid
liraglutideSaxenda®	withheld as a small cell paid prescriptions in the quarter (2021Q1)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter³⁶No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter³⁶No row	withheld as a small cell paid prescriptions in the quarter (2021Q4)every reporting cell was withheld, so nothing is observable³⁶Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter³⁵No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter³⁵No row	withheld as a small cell paid prescriptions in the quarter (2022Q4)every reporting cell was withheld, so nothing is observable³⁵Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter³⁴No row	withheld as a small cell paid prescriptions in the quarter (2023Q2)every reporting cell was withheld, so nothing is observable³⁴Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter³⁴No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q2)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q3)the dataset publishes no row for this product, state and quarter³³No row	no row published paid prescriptions in the quarter (2024Q4)the dataset publishes no row for this product, state and quarter³³No row	withheld as a small cell paid prescriptions in the quarter (2025Q1)every reporting cell was withheld, so nothing is observable³²Withheld1 of 1 product codes withheld	no row published paid prescriptions in the quarter (2025Q2)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q3)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2025Q4)the dataset publishes no row for this product, state and quarter³²No row	no row published paid prescriptions in the quarter (2026Q1)the dataset publishes no row for this product, state and quarter³¹No row
liraglutideVictoza®range 990 to 1,996	1,996 paid prescriptions in the quarter (2021Q1)⁴²Count$1,753,315 paid	1,964 paid prescriptions in the quarter (2021Q2)⁴²Count$1,765,082 paid	1,905 paid prescriptions in the quarter (2021Q3)⁴²Count$1,672,322 paid	1,799 paid prescriptions in the quarter (2021Q4)⁴²Count$1,592,327 paid	1,769 paid prescriptions in the quarter (2022Q1)⁴¹Count$1,644,824 paid	1,671 paid prescriptions in the quarter (2022Q2)⁴¹Count$1,568,405 paid	1,670 paid prescriptions in the quarter (2022Q3)⁴¹Count$1,560,560 paid	1,519 paid prescriptions in the quarter (2022Q4)⁴¹Count$1,412,914 paid	at least 1,599 paid prescriptions in the quarter (2023Q1)a floor, because some reporting cells were withheld⁴⁰At least$1,556,533 paid	at least 1,476 paid prescriptions in the quarter (2023Q2)a floor, because some reporting cells were withheld⁴⁰At least$1,436,820 paid	1,304 paid prescriptions in the quarter (2023Q3)⁴⁰Count$1,268,462 paid	1,245 paid prescriptions in the quarter (2023Q4)⁴⁰Count$1,207,771 paid	990 paid prescriptions in the quarter (2024Q1)³⁹Count$688,932 paid	at least 909 paid prescriptions in the quarter (2024Q2)a floor, because some reporting cells were withheld³⁹At least$621,837 paid	at least 234 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld³⁹At least$146,564 paid	at least 199 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld³⁹At least$134,972 paid	at least 13 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld³⁸At least$7,272 paid	withheld as a small cell paid prescriptions in the quarter (2025Q2)every reporting cell was withheld, so nothing is observable³⁸Withheld4 of 4 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q3)every reporting cell was withheld, so nothing is observable³⁸Withheld2 of 2 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2025Q4)every reporting cell was withheld, so nothing is observable³⁸Withheld3 of 3 product codes withheld	withheld as a small cell paid prescriptions in the quarter (2026Q1)every reporting cell was withheld, so nothing is observable³⁷Withheld3 of 3 product codes withheld
liraglutideliraglutide (generic)	no row published paid prescriptions in the quarter (2021Q1)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q2)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q3)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2021Q4)the dataset publishes no row for this product, state and quarter⁴⁸No row	no row published paid prescriptions in the quarter (2022Q1)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q2)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q3)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2022Q4)the dataset publishes no row for this product, state and quarter⁴⁷No row	no row published paid prescriptions in the quarter (2023Q1)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q2)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q3)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2023Q4)the dataset publishes no row for this product, state and quarter⁴⁶No row	no row published paid prescriptions in the quarter (2024Q1)the dataset publishes no row for this product, state and quarter⁴⁵No row	withheld as a small cell paid prescriptions in the quarter (2024Q2)every reporting cell was withheld, so nothing is observable⁴⁵Withheld1 of 1 product codes withheld	at least 656 paid prescriptions in the quarter (2024Q3)a floor, because some reporting cells were withheld⁴⁵At least$388,193 paid	at least 677 paid prescriptions in the quarter (2024Q4)a floor, because some reporting cells were withheld⁴⁵At least$400,726 paid	at least 1,234 paid prescriptions in the quarter (2025Q1)a floor, because some reporting cells were withheld⁴⁴At least$637,657 paid	at least 2,101 paid prescriptions in the quarter (2025Q2)a floor, because some reporting cells were withheld⁴⁴At least$983,226 paid	at least 2,573 paid prescriptions in the quarter (2025Q3)a floor, because some reporting cells were withheld⁴⁴At least$1,143,114 paid	at least 3,025 paid prescriptions in the quarter (2025Q4)a floor, because some reporting cells were withheld⁴⁴At least$996,913 paid	at least 2,803 paid prescriptions in the quarter (2026Q1)a floor, because some reporting cells were withheld⁴³At least$773,447 paid

What this page cannot tell you

Whether Oregon Health Plan covers these products is decided by a document this site has not read yet: its preferred drug list and the prior-authorization criteria behind it. Until that is read and quoted, the payment history above is all this page asserts. Start from the notice or the drug list the program sent you, and check which document governs your plan first, because no state rule reaches a self-funded employer plan at all.

Open Oregon in the coverage explorer to see all 21 quarters of trend per product and switch jurisdictions without leaving the table.

Compare another jurisdiction from the national comparison.

Documents this page reads

48 documents, cited by number above. Each opens to its section, its effective date, and the quote the fact came from.

SDUD 2026, Zepbound, OR
State Drug Utilization Data 2026, Datastore query result, product_name like ZEPBOUND%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "615"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Zepbound, OR
State Drug Utilization Data 2025, Datastore query result, product_name like ZEPBOUND%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "false", "number_of_prescriptions": "590"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Zepbound, OR
State Drug Utilization Data 2024, Datastore query result, product_name like ZEPBOUND%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Zepbound, OR
State Drug Utilization Data 2023, Datastore query result, product_name like ZEPBOUND%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "ZEPBOUND ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Zepbound, OR
State Drug Utilization Data 2022, Datastore query result, product_name like ZEPBOUND%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like ZEPBOUND%, state OR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Zepbound, OR
State Drug Utilization Data 2021, Datastore query result, product_name like ZEPBOUND%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like ZEPBOUND%, state OR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Mounjaro, OR
State Drug Utilization Data 2026, Datastore query result, product_name like MOUNJARO%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "288"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Mounjaro, OR
State Drug Utilization Data 2025, Datastore query result, product_name like MOUNJARO%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "356"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Mounjaro, OR
State Drug Utilization Data 2024, Datastore query result, product_name like MOUNJARO%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "196"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Mounjaro, OR
State Drug Utilization Data 2023, Datastore query result, product_name like MOUNJARO%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "115"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Mounjaro, OR
State Drug Utilization Data 2022, Datastore query result, product_name like MOUNJARO%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "MOUNJARO 5", "suppression_used": "false", "number_of_prescriptions": "17"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Mounjaro, OR
State Drug Utilization Data 2021, Datastore query result, product_name like MOUNJARO%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like MOUNJARO%, state OR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Wegovy, OR
State Drug Utilization Data 2026, Datastore query result, product_name like WEGOVY%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "WEGOVY 2.4", "suppression_used": "false", "number_of_prescriptions": "110"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Wegovy, OR
State Drug Utilization Data 2025, Datastore query result, product_name like WEGOVY%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "false", "number_of_prescriptions": "111"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Wegovy, OR
State Drug Utilization Data 2024, Datastore query result, product_name like WEGOVY%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 0.2", "suppression_used": "false", "number_of_prescriptions": "68"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Wegovy, OR
State Drug Utilization Data 2023, Datastore query result, product_name like WEGOVY%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Wegovy, OR
State Drug Utilization Data 2022, Datastore query result, product_name like WEGOVY%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "2", "utilization_type": "MCOU", "product_name": "WEGOVY ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Wegovy, OR
State Drug Utilization Data 2021, Datastore query result, product_name like WEGOVY%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "WEGOVY 1MG", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Ozempic, OR
State Drug Utilization Data 2026, Datastore query result, product_name like OZEMPIC%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "2758"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Ozempic, OR
State Drug Utilization Data 2025, Datastore query result, product_name like OZEMPIC%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "3308"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Ozempic, OR
State Drug Utilization Data 2024, Datastore query result, product_name like OZEMPIC%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 2M", "suppression_used": "false", "number_of_prescriptions": "2658"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Ozempic, OR
State Drug Utilization Data 2023, Datastore query result, product_name like OZEMPIC%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "1618"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Ozempic, OR
State Drug Utilization Data 2022, Datastore query result, product_name like OZEMPIC%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "3", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "861"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Ozempic, OR
State Drug Utilization Data 2021, Datastore query result, product_name like OZEMPIC%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "OZEMPIC 0.", "suppression_used": "false", "number_of_prescriptions": "408"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Rybelsus, OR
State Drug Utilization Data 2026, Datastore query result, product_name like RYBELSUS%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "62"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Rybelsus, OR
State Drug Utilization Data 2025, Datastore query result, product_name like RYBELSUS%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "124"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Rybelsus, OR
State Drug Utilization Data 2024, Datastore query result, product_name like RYBELSUS%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "RYBELSUS 1", "suppression_used": "false", "number_of_prescriptions": "128"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Rybelsus, OR
State Drug Utilization Data 2023, Datastore query result, product_name like RYBELSUS%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "118"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Rybelsus, OR
State Drug Utilization Data 2022, Datastore query result, product_name like RYBELSUS%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "66"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Rybelsus, OR
State Drug Utilization Data 2021, Datastore query result, product_name like RYBELSUS%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "RYBELSUS 7", "suppression_used": "false", "number_of_prescriptions": "30"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Saxenda, OR
State Drug Utilization Data 2026, Datastore query result, product_name like SAXENDA%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like SAXENDA%, state OR, 2026", "result_count": 0}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Saxenda, OR
State Drug Utilization Data 2025, Datastore query result, product_name like SAXENDA%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Saxenda, OR
State Drug Utilization Data 2024, Datastore query result, product_name like SAXENDA%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like SAXENDA%, state OR, 2024", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Saxenda, OR
State Drug Utilization Data 2023, Datastore query result, product_name like SAXENDA%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "2", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Saxenda, OR
State Drug Utilization Data 2022, Datastore query result, product_name like SAXENDA%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Saxenda, OR
State Drug Utilization Data 2021, Datastore query result, product_name like SAXENDA%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2021", "quarter": "4", "utilization_type": "MCOU", "product_name": "SAXENDA ", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Victoza, OR
State Drug Utilization Data 2026, Datastore query result, product_name like VICTOZA%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "true", "number_of_prescriptions": null}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Victoza, OR
State Drug Utilization Data 2025, Datastore query result, product_name like VICTOZA%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "13"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Victoza, OR
State Drug Utilization Data 2024, Datastore query result, product_name like VICTOZA%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "591"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Victoza, OR
State Drug Utilization Data 2023, Datastore query result, product_name like VICTOZA%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2023", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "977"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Victoza, OR
State Drug Utilization Data 2022, Datastore query result, product_name like VICTOZA%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2022", "quarter": "1", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1169"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Victoza, OR
State Drug Utilization Data 2021, Datastore query result, product_name like VICTOZA%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2021", "quarter": "2", "utilization_type": "MCOU", "product_name": "VICTOZA 6M", "suppression_used": "false", "number_of_prescriptions": "1247"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2026, Liraglutid, OR
State Drug Utilization Data 2026, Datastore query result, product_name like LIRAGLUTID%, state OR, 2026
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 10, 2026 · SDUD 2026 file, distribution 3bf6d0ed-f534-5dad-89da-29c7f99933be, CMS modified 2026-07-10 · Read Aug 11, 2026
{"state": "OR", "year": "2026", "quarter": "1", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "571"}
Read Aug 11, 2026 · effective Jul 10, 2026
SDUD 2025, Liraglutid, OR
State Drug Utilization Data 2025, Datastore query result, product_name like LIRAGLUTID%, state OR, 2025
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2025 file, distribution a613f4ae-0615-572c-812a-a381379914cd, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2025", "quarter": "4", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "678"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2024, Liraglutid, OR
State Drug Utilization Data 2024, Datastore query result, product_name like LIRAGLUTID%, state OR, 2024
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2024 file, distribution 7c764387-5eaf-57da-bc5e-b9b7e0b86bad, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "year": "2024", "quarter": "3", "utilization_type": "MCOU", "product_name": "LIRAGLUTID", "suppression_used": "false", "number_of_prescriptions": "455"}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2023, Liraglutid, OR
State Drug Utilization Data 2023, Datastore query result, product_name like LIRAGLUTID%, state OR, 2023
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2023 file, distribution df8055e5-3a20-5434-8a89-0e16073c8134, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like LIRAGLUTID%, state OR, 2023", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2022, Liraglutid, OR
State Drug Utilization Data 2022, Datastore query result, product_name like LIRAGLUTID%, state OR, 2022
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2022 file, distribution 54f6377c-5819-50cb-8b11-fc9a64e60246, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like LIRAGLUTID%, state OR, 2022", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026
SDUD 2021, Liraglutid, OR
State Drug Utilization Data 2021, Datastore query result, product_name like LIRAGLUTID%, state OR, 2021
Centers for Medicare & Medicaid Services · Federal agency publication · Effective Jul 13, 2026 · SDUD 2021 file, distribution 99089534-5317-54ee-85a8-b11558e4c907, CMS modified 2026-07-13 · Read Aug 11, 2026
{"state": "OR", "product_name": "product_name like LIRAGLUTID%, state OR, 2021", "result_count": 0}
Read Aug 11, 2026 · effective Jul 13, 2026

How the quoted row is presented, for 40 of these documents

One row of the API response for the query in url, with the fields that do not bear on this fact omitted and the rest left exactly as the API returns them, including the trailing spaces the ten-character product_name field pads with. Open the url to re-read the whole result set and re-sum it.

How the quoted row is presented, for 8 of these documents

The query in url returns an empty result set, which is the evidence. An absence cannot be quoted, so the record states the query and its count instead.

Common questions

Does a paid prescription mean Oregon Health Plan covers the drug?

No. A paid claim is a record of what happened in a past quarter. The rule that decides the next request is published separately, and a program can pay a claim in one quarter and exclude the product in the next. Where this site holds the published rule, the jurisdiction page for that program quotes it.

Why do two brands of the same molecule show different numbers?

Because a payer answers each brand separately. Semaglutide is sold as Wegovy® for weight management and as Ozempic® for type 2 diabetes, and the two carry different licences. The table lists them as separate rows for that reason.

What does a withheld figure mean?

The federal file suppresses a count too small to publish. Prescriptions were paid for and the number is not disclosed, so it is not a zero. Where part of a total was withheld, the figure shown is a floor.